FDA Approves Devicor’s Mammotome® revolve™ Biopsy System

Devicor® Medical Products, Inc. has announced that the US FDA has approved Mammotome® revolve™, a dual vacuum-assisted biopsy system, for use on patients.



Devicor Announces FDA Approves Mammotome® revolve™ Biopsy System (via PR Newswire)

CINCINNATI, Dec. 6, 2012 /PRNewswire/ — Devicor® Medical Products, Inc. (Devicor) announced today that the U.S. Food and Drug Administration (FDA) has approved Mammotome® revolve™, a dual vacuum-assisted biopsy system, for use on patients.  Mammotome® revolve™ is the next generation biopsy…


published: December 17, 2012 in: Approval/Clearance, Oncology

Most read

Latest

^